Oncology Decoded
Episodes
25: What Role Will The EV-304 Regimen Occupy in The Bladder Cancer Paradigm?
16 Apr 2026
Contributed by Lukas
In the latest episode of Oncology Decoded, hosts Manojkumar Bupathi, MD, MS; and Benjamin Garmezy, MD, spoke about the clinical utility of enfortumab...
24: How Will Data From ASCO GU 2026 Impact the Treatment Paradigm?
26 Mar 2026
Contributed by Lukas
Following the 2026 American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium, Oncology Decoded hosts Manojkumar Bupathi, MD, MS; a...
24: Reducing Disease Risk on National Cancer Prevention Month
27 Feb 2026
Contributed by Lukas
As part of honoring National Cancer Prevention Month in February, RadOnc on the Run host Brandon Mancini MD, MBA, spoke with Jenni Beamer about a bro...
23: Decoding Key Community Oncology Takeaways From ASCO GI 2026
26 Feb 2026
Contributed by Lukas
In the latest episode of Oncology Decoded, hosts Manojkumar Bupathi, MD, MS; and Benjamin Garmezy, MD, convened with Meredith Pelster, MD, MSCI; and ...
22: International Perspectives in Prostate Cancer: A Look at Treatment in India
19 Feb 2026
Contributed by Lukas
In a special episode of Oncology Decoded, hosts Manojkumar Bupathi, MD, MS, and Benjamin Garmezy, MD, spoke with their colleague Debapriya Mondal, MB...
21: Decoding the Top Moments in Prostate Cancer From 2025
22 Jan 2026
Contributed by Lukas
In the latest episode of Oncology Decoded, hosts Manojkumar Bupathi, MD, MS, and Benjamin Garmezy, MD, wound the clock back to 2025 to discuss the ke...
20: 20: What Were The Key Kidney and Bladder Cancer Advances in 2025?
08 Jan 2026
Contributed by Lukas
As part of ushering in the new year, Oncology Decoded hosts Manojkumar Bupathi, MD, MS, and Benjamin Garmezy, MD, looked back on the most exciting adv...
19: How to Manage Oligometastatic Kidney Cancer? Insights From IKCS 2025
04 Dec 2025
Contributed by Lukas
In the latest episode of Oncology Decoded, hosts Manojkumar Bupathi, MD, MS, and Benjamin Garmezy, MD, broke down the treatment decision-making proces...
18: What Were The Most Impactful GU Oncology Data From ESMO 2025?
06 Nov 2025
Contributed by Lukas
Following the European Society for Medical Oncology (ESMO) Congress 2025, Oncology Decoded hosts Manojkumar Bupathi, MD, MS, and Benjamin Garmezy, MD,...
17: Exploring the ESMO 2025 Presentations That May Shift GU Oncology
16 Oct 2025
Contributed by Lukas
Ahead of the European Society for Medical Oncology Congress (ESMO) 2025, Oncology Decoded hosts Manojkumar Bupathi, MD, MS, and Benjamin Garmezy, MD, ...
16: Diving Into the Practical Applications of ctDNA in Oncology Care
25 Sep 2025
Contributed by Lukas
In this episode of Oncology Decoded, hosts Manojkumar Bupathi, MD, MS, and Benjamin Garmezy, MD, discussed the role that circulating tumor DNA (ctDNA)...
15: Gathering the Latest Multidisciplinary Care Insights Across World GU 2025
18 Sep 2025
Contributed by Lukas
While attending the 2025 World Conference on Genitourinary Cancers (World GU), Oncology Decoded hosts Manojkumar Bupathi, MD, MS, and Benjamin Garmezy...
14: Elevating Community Oncology Care: Insights From World GU 2025
12 Sep 2025
Contributed by Lukas
Oncology Decoded hosts Manojkumar Bupathi, MD, MS, and Benjamin Garmezy, MD, traveled to the 2025 World Conference on Genitourinary Cancers (World GU...
13: Optimizing Care Planning for Variant Histology Populations at World GU 2025
11 Sep 2025
Contributed by Lukas
In this episode of Oncology Decoded, hosts Manojkumar Bupathi, MD, MS, and Benjamin Garmezy, MD, traveled to the 2025 World Conference on Genitourinar...
12: Beyond the BEP: A Deep Dive into Testicular Cancer Management
28 Aug 2025
Contributed by Lukas
In this episode of Oncology Decoded, hosts Manojkumar Bupathi, MD, MS, and Benjamin Garmezy, MD, spoke with Nabil Adra, MD, about testicular cancer ca...
11: Navigating the Evolving Second-Line Landscape of Metastatic Urothelial Carcinoma
14 Aug 2025
Contributed by Lukas
The latest Oncology Decoded discussion with Manojkumar Bupathi, MD, MS, executive cochair of the Genitourinary Cancer Research Executive Committee at ...
10: Navigating Second-Line Treatment Options in Urothelial Carcinoma
31 Jul 2025
Contributed by Lukas
This episode of Oncology Decoded focuses on a discussion between hosts Manojkumar Bupathi, MD, MS, executive cochair of the Genitourinary Cancer Resea...
9: Unveiling Advances in GU Cancers: Insights from Oncology Decoded
03 Jul 2025
Contributed by Lukas
The Oncology Decoded podcast, co-hosted by Manojkumar Bupathi, MD, MS, executive cochair of the Genitourinary Cancer Research Executive Committee at S...
8: ASCO 2025 Debrief: Key Updates in Genitourinary Cancer Management
19 Jun 2025
Contributed by Lukas
As part of the latest Oncology Decoded discussion, Manojkumar Bupathi, MD, MS, met with Benjamin Garmezy, MD, after the 2025 American Society of Clini...
7: Sharpening the Prostate Cancer Toolkit: Practical Insights on PSMA Imaging
05 Jun 2025
Contributed by Lukas
Experts weigh in on the practical applications of PSMA PET imaging, risk stratification, and evolving treatment strategies for advanced prostate cance...
6: A Sneak Peek at 2025 ASCO From the GU Perspective
15 May 2025
Contributed by Lukas
In this special episode of Oncology Decoded, hosts Manojkumar Bupathi, MD, MS, and Benjamin Garmezy, MD, discussed the highly anticipated 2025 America...
5: Beyond Surgery: The Evolving Landscape of Adjuvant Therapy in Kidney Cancer
01 May 2025
Contributed by Lukas
Manojkumar Bupathi, MD, MS; and Benjamin Garmezy, MD, dove into the complexities of adjuvant therapy for kidney cancer, providing valuable insights fo...
4: Adjuvant Therapy and Post-Surgical Management Options for Kidney Cancer
01 Apr 2025
Contributed by Lukas
In the most recent episode of Oncology Decoded, co-hosts Manojkumar Bupathi, MD, MS, executive co-chair of Genitourinary Cancer Research Executive Com...
3: Traversing the Complexities of Non-Clear Cell Renal Cell Carcinoma
07 Mar 2025
Contributed by Lukas
This episode of Oncology Decoded tackled the challenging landscape of non-clear cell renal cell carcinoma (nccRCC), a heterogeneous group of tumors re...
2: Navigating Treatment Intensification in Metastatic Hormone-Sensitive Prostate Cancer
05 Mar 2025
Contributed by Lukas
When treating hormone-sensitive prostate cancer (mHSPC), one question can be, when is the right time to optimize or intensify therapy? In the latest O...
1: NIAGARA Study is the Forefront of Post-ASCO GU Discussion in Bladder Cancer
04 Mar 2025
Contributed by Lukas
During the 2025 ASCO Genitourinary Cancers Symposium, Oncology Decoded held their inaugural podcast with a live filming taking place at the conference...